SK pharmteco

Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Find alternatives to SK pharmteco for Viral Vectors →
Claimed Profile Viral Vectors AAV Lentiviral Adenoviral HPAPIs Small Molecules Peptides BioCatalysis Chromatography Cell Therapy
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
79.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1) ✓ EMA GMP (3) ○ MHRA GMP

Quick Facts: SK pharmteco

Signal Score
79.5/100 (as of 2026-10-29)
Quality Compliance
100.0/100 — Clean EMA record: 3 active GMP certificates (no deductions)
Headquarters
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Website
Modalities
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Clean EMA record: 3 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 3 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates3 on record
Clean EMA record: 3 active GMP certificates (no deductions)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesViral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 63.0
Broad modality coverage (10 modalities)
Sites: Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
StatusAvailable
Broad modality coverage (10 modalities)
Sites: Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Press Signals1 articles (not scored)
Broad modality coverage (10 modalities)

SK pharmteco EMA GMP Compliance 3 certificates

2025-11
2025-11
2022-04
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
2026_HPF_FR_076_IV YposKesi France 2025-11-28 COMPLIANT
2026_HPF_FR_075_IV YposKesi France 2025-11-28 COMPLIANT
2022_HPF_FR_143_1_P_2025 YposKesi France 2022-04-08 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Hiring Activity Beta

From public job postings on SK pharmteco's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No open roles were listed on Nov 20, 2026.
Coverage: counted from SK pharmteco's own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: skpharmteco.com · Checked Nov 20, 2026 · Tracking since Oct 30, 2026

Company Signals 1 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-09-29
Exclusive: SK pharmteco unveils $200M+ investment to expand CDMO capabilities - Endpoints News
Exclusive: SK pharmteco unveils $200M+ investment to expand CDMO capabilities  Endpoints News

Frequently Asked Questions About SK pharmteco

Does SK pharmteco hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA GMP certificates for SK pharmteco.
What is SK pharmteco's CDMO Signal Score?
SK pharmteco has a Signal Score of 80/100, based on quality, operations, financial stability, and capacity data.
Evaluating SK pharmteco for a manufacturing program?
Use the free AI matchmaker to compare SK pharmteco against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Viral Vectors CDMOs → AAV CDMOs → Lentiviral CDMOs → Adenoviral CDMOs → HPAPIs CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
NecstGen
Leiden, NL
Signal Score: 78.1
AAV, Lentiviral, Cell Therapy
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral

Compare SK pharmteco with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on SK pharmteco
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.